Probiotics as Beneficial Dietary Supplements to Prevent and Treat Cardiovascular Diseases: Uncovering Their Impact on Oxidative Stress
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
The gut microbiota, the ecosystem formed by a wide symbiotic community of nonpathogenic microorganisms that are present in the distal part of the human gut, plays a prominent role in the normal physiology of the organism. The gut microbiota’s imbalance, gut dysbiosis, is directly related to the origin of various processes of acute or chronic dysfunction in the host. Therefore, the ability to intervene in the gut microbiota is now emerging as a possible tactic for therapeutic intervention in various diseases. From this perspective, evidence is growing that a functional dietary intervention with probiotics, which maintain or restore beneficial bacteria of the digestive tract, represents a promising therapeutic strategy for interventions in cardiovascular diseases and also reduces the risk of their occurrence. In the present work, we review the importance of maintaining the balance of the intestinal microbiota to prevent or combat such processes as arterial hypertension or endothelial dysfunction, which underlie many cardiovascular disorders. We also review how the consumption of probiotics can improve autonomic control of cardiovascular function and provide beneficial effects in patients with heart failure. Among the known effects of probiotics is their ability to decrease the generation of reactive oxygen species and, therefore, reduce oxidative stress. Therefore, in this review, we specifically focus on this antioxidant capacity and its relationship with the beneficial cardiovascular effects described for probiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592 · cited 1×
“This definition, established by the joint Food and Agriculture Organization of the United Nations (FAO) and World Health Organization (WHO) Working Group, is the one used today and accepted by the International Scientific Association for Probiotics and Prebiotics (ISAPP) [14].”
MethodJames, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950 · cited 1×
“Several international reports, mainly those prepared by the Eighth Joint National Committee (JNC 8), have established the guidelines for the treatment of hypertensive patients and different reference values for those over 60 years old [21].”
BackgroundGlobal Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
Forouzanfar, M. H., Liu, P., Roth, G. A., Ng, M., Biryukov, S., Marczak, L., Alexander, L., Estep, K., Hassen Abate, K., Akinyemiju, T. F., et al. (2017) · JAMA · doi:10.1001/jama.2016.19043 · Cited by 2,381 · cited 1×
“Arterial hypertension constitutes a main risk factor for the development of severe pathologies, such as acute myocardial infarction, heart failure, stroke, and renal failure [15–17], as well as for premature death worldwide [18].”
BackgroundRoles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis
Förstermann, U., Xia, N., & Li, H. (2017) · Circulation Research · doi:10.1161/circresaha.116.309326 · Cited by 1,519 · cited 1×
“In fact, the generation of ROS caused by hypertension, hypercholesterolemia, diabetes, or other cardiovascular risk factors causes a decrease in the release of endothelial NO [56].”
BackgroundThe vagus nerve at the interface of the microbiota-gut-brain axis
Bonaz, B., Bazin, T., & Pellissier, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00049 · Cited by 1,397
Dietary metabolism, the gut microbiome, and heart failure
Tang, W. H. W., Li, D. Y., & Hazen, S. L. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0108-7 · Cited by 789 · cited 2×
“In fact, intestinal microbes participate in the phosphatidylcholine metabolism and in the increased TMAO levels, which was independently associated with major cardiovascular events [70] and the incidence of chronic kidney diseases [79].”
BackgroundInteractions of commensal and pathogenic microorganisms with the intestinal mucosal barrier
Martens, E. C., Neumann, M., & Desai, M. S. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0036-x · Cited by 711
Vascular endothelium – Gatekeeper of vessel health
Cahill, P. A., & Redmond, E. M. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.03.007 · Cited by 518
Khalesi, S., Sun, J., Buys, N., & Jayasinghe, R. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03469 · Cited by 516 · cited 1×
“Finally, the duration of the intervention must be ≥8 weeks, and the dose of daily consumption of probiotics should be ≥10(11) colony-forming units [40].”
BackgroundSecondary arterial hypertension: when, who, and how to screen?
Rimoldi, S. F., Scherrer, U., & Messerli, F. H. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht534 · Cited by 393 · cited 1×
“Approximately 8% of cases exhibit secondary hypertension, which has a known origin, including endocrine diseases, drugs, cancer, or hyperactivation of the renin-angiotensin system, among others [20].”
BackgroundThe mucosal immune system: master regulator of bidirectional gut-brain communications
Powell, N., Walker, M. M., & Talley, N. J. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.191 · Cited by 379 · cited 2×
“Others have attempted to address the question by proposing relevant interactions between gut endocrine cells and vagal afferents through gut chemosensing mechanisms [65, 66].”
BackgroundResultNoble, E. E., Hsu, T. M., & Kanoski, S. E. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00009 · Cited by 333 · cited 1×
“Others have attempted to address the question by proposing relevant interactions between gut endocrine cells and vagal afferents through gut chemosensing mechanisms [65, 66].”
BackgroundGan, X. T., Ettinger, G., Huang, C. X., Burton, J. P., Haist, J. V., Rajapurohitam, V., Sidaway, J. E., Martin, G., Gloor, G. B., Swann, J. R., et al. (2014) · Circulation: Heart Failure · doi:10.1161/circheartfailure.113.000978 · Cited by 329 · cited 1×
“[81] showed improved ventricular function and structure after treatment with the probiotic Lactobacillus rhamnosus.”
BackgroundA Combined Epidemiologic and Metabolomic Approach Improves CKD Prediction
Rhee, E. P., Clish, C. B., Ghorbani, A., Larson, M. G., Elmariah, S., McCabe, E., Yang, Q., Cheng, S., Pierce, K., Deik, A., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012101006 · Cited by 307
Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis
Nagatomo, Y., & Tang, W. H. W. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.09.017 · Cited by 259 · cited 1×
“This phenomenon might be explained by the so-called “gut hypothesis,” in which the reduced cardiac pumping function and congestion observed in HF patients would be responsible for an intestinal ischemia [71], favoring bacterial translocation and increases in circulating endotoxins that elicit inflammation [72].”
BackgroundTrimethylamine N-oxide and prognosis in acute heart failure
Suzuki, T., Heaney, L. M., Bhandari, S. S., Jones, D. J. L., & Ng, L. L. (2016) · Heart · doi:10.1136/heartjnl-2015-308826 · Cited by 253
Intestinal Blood Flow in Patients With Chronic Heart Failure
Sandek, A., Swidsinski, A., Schroedl, W., Watson, A., Valentova, M., Herrmann, R., Scherbakov, N., Cramer, L., Rauchhaus, M., Grosse-Herrenthey, A., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1179 · Cited by 239 · cited 1×
“In fact, the intestinal blood flow is reduced in HF patients, contributing to juxtamucosal bacterial growth [73].”
BackgroundGut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts
Kummen, M., Mayerhofer, C. C. K., Vestad, B., Broch, K., Awoyemi, A., Storm-Larsen, C., Ueland, T., Yndestad, A., Hov, J. R., & Trøseid, M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.057 · Cited by 227 · cited 1×
“[74] reported that the gut microbiota in HF patients is related to persistent Tcell activation.”
BackgroundCostanza, A. C., Moscavitch, S. D., Faria Neto, H. C. C., & Mesquita, E. T. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.11.034 · Cited by 182
Cited by
Feng, T., & Wang, J. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1801944 · Cited by 621
Modulatory Effects of Probiotics During Pathogenic Infections With Emphasis on Immune Regulation
Raheem, A., Liang, L., Zhang, G., & Cui, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.616713 · Cited by 302
Pourrajab, B., Fatahi, S., Sohouli, M. H., Găman, M.-A., & Shidfar, F. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1821166 · Cited by 82
Noormohammadi, M., Ghorbani, Z., Löber, U., Mahdavi-Roshan, M., Bartolomaeus, T. U. P., Kazemi, A., Shoaibinobarian, N., & Forslund, S. K. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2022.106614 · Cited by 40
Mahapatro, A., Bawna, F., Kumar, V., Daryagasht, A. A., Gupta, S., Raghuma, N., Moghdam, S. S., Kolla, A., Mahapatra, S. S., Sattari, N., et al. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.07.087 · Cited by 37
Metadata
- Authors
- Vasquez, E. C., Pereira, T. M. C., Peotta, V. A., Baldo, M. P., & Campos-Toimil, M.
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2019-05-07
- Volume
- 2019
- Pages
- 1-11
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- OpenAlex
- W2944001215
- Cited by
- 98
- References
- 19
- FWCI
- 9.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.